Filing Details

Accession Number:
0001062993-22-014816
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-13 17:44:07
Reporting Period:
2022-06-09
Accepted Time:
2022-06-13 17:44:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1661181 Organogenesis Holdings Inc. ORGO Biological Products, (No Disgnostic Substances) (2836) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1074084 Albert Erani C/O Rugby Realty Co., Inc.
300 Lighting Way, Ste 210
Secaucus NJ 07094
No No Yes No
1757452 Gn 2016 Organo 10-Year Grat U/A/D September 30, 2016 35 Sawgrass Drive
Bellport NY 11713
No No Yes No
1760685 Dennis Erani 6000 Island Boulevard
Apt. 2502
Aventura FL 33160
No No Yes No
1900525 Red Holdings, Llc C/O Rugby Realty Co., Inc.
300 Lighting Way, Ste 210
Secaucus NJ 07094
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2022-06-09 331 $5.30 59,277,696 No 4 S Direct
Class A Common Stock Disposition 2022-06-13 29,669 $4.89 59,248,027 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.31, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
  2. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $4.83 to $4.95, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
  3. Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to this Form 4.